FMCSA Reverses Course, Denies Epilepsy Driver Exemptions

The Federal Motor Carrier Safety Administration has abruptly reversed its permissive stance on medical exemptions for commercial drivers with epilepsy, denying 70 applications across two recent Federal Register actions in June and July 2026. This represents a stark departure from nearly two years of routine approvals, though the agency maintains it applies the same individualized assessment criteria in both approvals and denials. The timing and lack of announced policy change raise questions about FMCSA's decision-making framework.

The agency approved 63 exemptions just five days before denying 52 applications, suggesting inconsistent application of safety standards or undisclosed shifts in interpretation. For carriers, this creates compliance uncertainty and potential staffing challenges, particularly for drivers who may have built their employment arrangements around the expectation of exemption renewal. The lack of response from FMCSA leadership to media inquiries about policy changes compounds the confusion.

Supply chain and logistics leaders should anticipate tighter enforcement of medical qualification standards and proactive review of existing exempted drivers' status. This signals a broader regulatory tightening that may extend beyond epilepsy to other medical conditions, reshaping driver retention strategies across the industry.